BALDWIN BROTHERS LLC/MA - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 268 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 3.49 and the average weighting 0.1%.

Quarter-by-quarter ownership
BALDWIN BROTHERS LLC/MA ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2023$3,509
+10.0%
1040.0%0.00%
Q3 2023$3,191
-23.4%
1040.0%0.00%
Q2 2023$4,167
-1.8%
1040.0%0.00%
Q1 2023$4,244
+5.7%
1040.0%0.00%
Q4 2022$4,0151040.00%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Tamarack Advisers, LP 550,000$18,442,0006.98%
Gagnon Advisors, LLC 193,860$6,500,0006.06%
GAGNON SECURITIES LLC 407,159$13,652,0004.64%
Spyglass Capital Management LLC 1,190,537$39,919,0004.51%
Paulson & Co. 1,716,727$57,562,0002.20%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,627,521$54,571,0001.73%
Elk Creek Partners, LLC 265,146$8,890,0001.53%
HealthCor Management, L.P. 887,370$29,754,0001.27%
Rock Springs Capital Management LP 900,000$30,177,0001.25%
Lisanti Capital Growth, LLC 108,679$3,644,0001.20%
View complete list of PACIRA PHARMACEUTICALS INC shareholders